prasugrel News
Most Popular prasugrel Story
How dangerous is Effient to Plavix?
Just how much danger does Plavix face from the new Effient approval? Depends on who's talking. Theoretically, the new Eli Lilly/Daiichi Sankyo blood thinner could significantly eat into the... Read more...
Latest Headlines
- September 4, 2009
- July 13, 2009
- April 8, 2009
- February 2, 2009
- January 30, 2009
- December 19, 2008
- November 12, 2008
- October 16, 2008
- June 24, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
